All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF1028 | Anti-Human B7-H3 (XW-108) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-108 | Humanized | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1029 | Anti-Human B7-H3 (XW-109) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-109 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1030 | Anti-Human B7-H3 (XW-110) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-110 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1031 | Anti-Mouse B7-H3 (XW-111) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-111 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1032 | Anti-Mouse B7-H3 (XW-112) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-112 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1033 | Anti-Human B7-H3 (XW-113) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-113 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1034 | Anti-Human B7-H3 (XW-114) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-114 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1035 | Anti-Human B7-H3 (XW-115) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-115 | Humanized | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1036 | Anti-Human B7-H3 (XW-116) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-116 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1037 | Anti-Human B7-H3 (XW-117) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-117 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1038 | Anti-Human B7-H3 (XW-118) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-118 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1039 | Anti-Human B7-H3 (XW-119) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-119 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1040 | Anti-Human B7-H3 (XW-120) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-120 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1041 | Anti-Human B7-H3 (XW-121) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-121 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1042 | Anti-Human B7-H3 (XW-122) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-122 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1948 | Anti-Human B7-H3 (XW-108) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-108 | Humanized | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1949 | Anti-Human B7-H3 (XW-109) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-109 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1950 | Anti-Human B7-H3 (XW-110) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-110 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1951 | Anti-Mouse B7-H3 (XW-111) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-111 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1952 | Anti-Mouse B7-H3 (XW-112) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-112 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION